Sat.Jul 09, 2022 - Fri.Jul 15, 2022

Moderna founder launches Apriori with $50M to stay ahead of virus variants

Bio Pharma Dive

Flagship Pioneering’s latest startup aims to use predictive technology to find “variant-proof” treatments and vaccines for infectious diseases before they might be needed

Pharma’s platinum handcuffs

World of DTC Marketing

To address the “retention” problem, pharma companies are paying employees exorbitant salaries. The problem with that system is that people do whatever they need to to “hold onto” their high-paying jobs and become employees who are content not to excel.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin.

F.D.A. to Weigh Over-the-Counter Sale of Birth Control Pills

NY Times

The first U.S. application for sale of a nonprescription birth control pill has taken on new meaning after the Supreme Court decision ending the constitutional right to abortion.

Sales 83

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

De-risking oncology trials with medical monitoring

Bio Pharma Dive

Phase three oncology studies have approximately a 35% likelihood of leading to regulatory approval

Trials 266

Are digital pharmacies the answer?

World of DTC Marketing

Digital pharmacies seem to be springing up everywhere. Allowing patients to order medications online and get delivery via Fed-Ex or the mail does offer time savings. Still, without a significant value (lower costs), they may not find an audience.

More Trending

Questions Frequently Asked Pertaining to Clinical Trials

Riverside Clinical Research

If you are considering playing a vital role in the advancement of medicine and medical technology by embarking on your first experience as a clinical trial volunteer, you most likely have a few questions about clinical research and the clinical trial process.

CytomX lays off staff, joining growing list of biotechs restructuring

Bio Pharma Dive

A shaky biotech market has forced another drugmaker to adjust, with CytomX revealing plans to reduce its workforce by 40

Can we get healthcare right?

World of DTC Marketing

Imbruvica, a cancer medication, carries a wholesale price of about $16,000 a month. Patients on Medicare who don’t qualify for low-income subsidies could see out-of-pocket costs for the drug of over $12,000. Isn’t it time for Congress to finally pass legislation that helps patients?

Vertex signs agreement to acquire ViaCyte for $320m

Pharmaceutical Technology

Vertex Pharmaceuticals has signed a definitive agreement for the acquisition of biotechnology company ViaCyte in a deal totalling $320m in cash. ViaCyte focuses on offering new stem cell-derived cell replacement therapies as a functional cure for type 1 diabetes (T1D).

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Walgreens Boots Alliance Increases Quarterly Dividend

BioTech 365

Walgreens Boots Alliance Increases Quarterly Dividend Walgreens Boots Alliance Increases Quarterly Dividend DEERFIELD, Ill.–(BUSINESS –(BUSINESS WIRE)–Walgreens Boots Alliance, Inc.


Agios CEO to step down, handing role to veteran in rare disease drug sales

Bio Pharma Dive

A former Celgene executive, Jackie Fouse has led Agios since 2019, overseeing its transformation into a company focused solely on uncommon diseases. In August, she will transition to chair its board of directors

Sales 255

Safer web surfing with a new method for detecting malicious modes


With the ever-increasing importance of the Internet in our lives, there are growing attempts to exploit software vulnerabilities in our PCs for personal benefit. One way to do so is by infecting the victim’s PC with a malicious code injected through a website.


AI in IVF: a fertile field

Pharmaceutical Technology

Despite entering its fourth decade of availability, in vitro fertilization (IVF), a medical technique used to facilitate the conception of a baby for those facing fertility problems, remains an elusive dream for many.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

U.S. Tells Pharmacists Not to Withhold Pills That Can Cause Abortion

NY Times

New Biden administration guidance warned that failing to dispense such drugs “may be discriminating” on the basis of sex or disability, citing other conditions that they can treat.

Drugs 81

Ultragenyx sells rare disease drug royalties to Canadian pension fund

Bio Pharma Dive

In exchange for $500 million, the fund, called OMERS, will get a 30% royalty on future sales of Ultragenyx’s drug Crysvita in the U.S. and Canada, where it’s approved to treat two rare conditions

Sales 251

7 Most Common Types of Depression

Olympian Clinical Research

Depression is an illness that affects nearly 280 million people worldwide. There are several types of depression, each with its own set of symptoms and recommended treatment methods.

Health Canada grants approval for Moderna’s Covid-19 vaccine in children

Pharmaceutical Technology

Health Canada has granted approval for the usage of Moderna’s messenger RNA (mRNA) Covid-19 vaccine, Spikevax, in a 25µg two-dose regimen for active immunisation to prevent Covid-19 in children aged six months to five years.

RNA 87

New Cambridge institute to house largest concentration of heart and lung researchers in Europe


HRH The Duchess of Gloucester will today officially open the Heart and Lung Research Institute (HLRI), a major new addition to the Cambridge Biomedical Campus.

EMA adds allergic reaction warning to Novavax's COVID-19 vaccine

Bio Pharma Dive

The regulator said there have been “a few” spontaneous severe allergic reactions following administration of the vaccine, which was this week authorized in the U.S.

Novo Nordisk, Eli Lilly poised to divvy up obesity market that could be worth $50B in 2030: analysts

Fierce Pharma

Novo Nordisk, Eli Lilly poised to divvy up obesity market that could be worth $50B in 2030: analysts. fkansteiner. Fri, 07/15/2022 - 11:22

Merck and Orion enter partnership to develop ODM-208 for prostate cancer

Pharmaceutical Technology

Merck (MSD outside North America) and Orion have entered an international agreement to develop and market the latter’s investigational candidate ODM-208 to treat metastatic castration-resistant prostate cancer (mCRPC).

Atomically-smooth gold crystals help to compress light for nanophotonic applications


KAIST researchers and their collaborators at home and abroad have successfully demonstrated a new platform for guiding the compressed light waves in very thin van der Waals crystals.

Vertex acquires another maker of potentially curative diabetes treatments

Bio Pharma Dive

For $320 million, Vertex said it plans to buy ViaCyte in a deal that would provide “complementary assets, capabilities and technologies” to the ones it picked up through the 2019 acquisition of Semma Therapeutics


Amazon and Fred Hutch team up on cancer vaccine trial

BioPharma Reporter

Amazon is partnering with the Fred Hutchinson Cancer Research Center on a Phase I trial for a cancer vaccine targeting metastatic melanoma and breast cancer. Bio Developments

US FDA approves Pfizer-BioNTech’s Covid-19 vaccine for adolescents

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for Pfizer and BioNTech’s supplemental Biologics License Application (sBLA) for their Covid-19 vaccine, Comirnaty, for adolescents aged 12 to 15 years.

Ames Laboratory is now Ames National Laboratory


AMES, IOWA—The U.S. Department of Energy’s Ames Laboratory has announced a name change, to Ames National Laboratory. Credit: U.S. Department of Energy, Ames National Laboratory AMES, IOWA—The U.S. Department of Energy’s Ames Laboratory has announced a name change, to Ames National Laboratory.


Verve starts first human test of gene editing treatment for heart disease

Bio Pharma Dive

A patient in New Zealand became the first person to receive the biotech’s medicine, which uses base editing to turn off a specific gene in the liver and thereby lower cholesterol

Moderna’s Nipah virus mRNA vaccine enters Phase 1 trial

BioPharma Reporter

Moderna has dosed the first participant in a Phase 1 trial of its Nipah virus vaccine candidate, mRNA-1215, that has been developed in collaboration with the US National Institutes of Health (NIH). Bio Developments

Trials 106

Supply chain & logistics innovation among pharma companies has dropped off in the last year

Pharmaceutical Technology

Research and innovation in supply chain & logistics in the pharmaceutical sector has declined in the last year.

Towards stable, sustained Raman imaging of large samples at the nanoscale


Raman spectroscopy, an optical microscopy technique, is a non-destructive chemical analysis technique that provides rich molecular fingerprint information about chemical structure, phase, crystallinity, and molecular interactions.

Novartis, Beigene cancer drug faces delay as FDA puts off approval decision

Bio Pharma Dive

The deferral puts the drug in regulatory limbo, setting back the Swiss pharma's efforts to catch up to top immunotherapy developers Merck, Bristol Myers Squibb and Roche

Akili digital therapeutic shows promise in lupus patients


Akili looks like it could bring another digital therapeutic (DTx) to market after a clinical trial backed the efficacy of its AKL-T01 in patients with the autoimmune disorder systemic lupus erythematosus (SLE).

Moderna's omicron booster triggers stronger response against subvariants than its original shot, company says

Fierce Pharma

Moderna's omicron booster triggers stronger response against subvariants than its original shot, company says. zbecker. Mon, 07/11/2022 - 10:44